AI in Biotech
Exciting advancements in AI are transforming the landscape of drug development by enhancing our understanding of human biology, which has historically been a challenge. With a staggering 85% of drugs failing in phase two trials due to a lack of biological insight, AI offers a promising solution to unravel complex biological targets. Additionally, leveraging AI in clinical trials could significantly reduce costs and improve success rates, paving the way for more effective treatments.In this clip
From this podcast
Raising Health
AI + a16z with Vijay Pande
Related Questions